: The AMEDEO Literature Guide

Home

Fast Track

My Amedeo

FAQ

About

Flying Publisher

	Fast Track

FPG #8: Alternative Treatments in Psychiatry
FPG #7: Critical Care in Neurology

Free Medical Books

Multiple Sclerosis

Free Subscription

Articles published in Mult Scler
Retrieve available abstracts of 465 articles:
HTML format
Text format

Single Articles

February 2012

FROMONT A , Binquet C, Sauleau E, Fournel I, et al
National estimate of multiple sclerosis incidence in France (2001-2007).
Mult Scler. 2012.
PubMed Text format Related articles Abstract available

GAFSON AR , Giovannoni G
Towards the incorporation of lumbar puncture into clinical trials for multiple sclerosis.
Mult Scler. 2012.
PubMed Text format Related articles

January 2012

VILLOSLADA P , Cuneo A, Gelfand J, Hauser SL, et al
Color vision is strongly associated with retinal thinning in multiple sclerosis.
Mult Scler. 2012.
PubMed Text format Related articles Abstract available

SIMON KC , O'Reilly EJ, Munger KL, Finerty S, et al
Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis.
Mult Scler. 2012.
PubMed Text format Related articles Abstract available

TILL C , Udler E, Ghassemi R, Narayanan S, et al
Factors associated with emotional and behavioral outcomes in adolescents with multiple sclerosis.
Mult Scler. 2012.
PubMed Text format Related articles Abstract available

GAVASSO S , Gjertsen B, Anderssen E, Myhr K, et al
Immunogenic effects of recombinant interferon-beta therapy disrupt the JAK/STAT pathway in primary immune cells from patients with multiple sclerosis.
Mult Scler. 2012.
PubMed Text format Related articles Abstract available

BENEDICT RH , Smerbeck A, Parikh R, Rodgers J, et al
Reliability and equivalence of alternate forms for the Symbol Digit Modalities Test: implications for multiple sclerosis clinical trials.
Mult Scler. 2012.
PubMed Text format Related articles Abstract available

COSSU D , Masala S, Cocco E, Paccagnini D, et al
Are Mycobacterium avium subsp. paratuberculosis and Epstein-Barr virus triggers of multiple sclerosis in Sardinia?
Mult Scler. 2012.
PubMed Text format Related articles Abstract available

AVSAR T , Korkmaz D, Tutuncu M, Demirci NO, et al
Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
Mult Scler. 2012.
PubMed Text format Related articles Abstract available

LUTTEROTTI A , Jelcic I, Schulze C, Schippling S, et al
No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients.
Mult Scler. 2012.
PubMed Text format Related articles Abstract available

PERUMAL JS , Foo F, Cook P, Khan O, et al
Subcutaneous administration of alemtuzumab in patients with highly active multiple sclerosis.
Mult Scler. 2012.
PubMed Text format Related articles Abstract available

GIOVANNONI G , Southam E, Waubant E
Systematic review of disease-modifying therapies to assess unmet needs in multiple sclerosis: tolerability and adherence.
Mult Scler. 2012.
PubMed Text format Related articles Abstract available

GALIMBERTI D
Corrigendum to Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid.
Mult Scler. 2012.
PubMed Text format Related articles

DESMAZIERES A , Sol-Foulon N, Lubetzki C
Changes at the nodal and perinodal axonal domains: a basis for multiple sclerosis pathology?
Mult Scler. 2012.
PubMed Text format Related articles Abstract available

HIRST CL , Ingram G, Pickersgill TP, Robertson NP, et al
Temporal evolution of remission following multiple sclerosis relapse and predictors of outcome.
Mult Scler. 2012.
PubMed Text format Related articles Abstract available

HANDEL AE , Ramagopalan SV
Vitamin D and multiple sclerosis: an interaction between genes and environment.
Mult Scler. 2012;18:2-4.
PubMed Text format Related articles

December 2011

AHLGREN C , Oden A, Lycke J
A nationwide survey of the prevalence of multiple sclerosis in immigrant populations of Sweden.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

ZIVADINOV R , Dwyer M, Hussein S, Carl E, et al
Voxel-wise magnetization transfer imaging study of effects of natalizumab and IFNbeta-1a in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

ERTL-WAGNER B , Koerte I, Kuempfel T, Blaschek A, et al
Non-specific alterations of craniocervical venous drainage in multiple sclerosis revealed by cardiac-gated phase-contrast MRI.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

VARADE J , Comabella M, Ortiz MA, Arroyo R, et al
Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CLBL genes.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

LANGDON D , Amato M, Boringa J, Brochet B, et al
Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

JELCIC I , Hsu KC, Kakalacheva K, Breiden P, et al
Killer immunoglobulin-like receptor locus polymorphisms in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

LECHNER-SCOTT J , Spencer B, de Malmanche T, Attia J, et al
The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

TREMLETT H
Epidemiology in multiple sclerosis has had its day: there are no more unanswered questions - No.
Mult Scler. 2011.
PubMed Text format Related articles

HUTCHINSON M
Epidemiology of multiple sclerosis has had its day: there are no more unanswered questions - Commentary.
Mult Scler. 2011.
PubMed Text format Related articles

FAY AJ , Mowry EM, Strober J, Waubant E, et al
Relapse severity and recovery in early pediatric multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

KAMINSKA M , Kimoff R, Benedetti A, Robinson A, et al
Obstructive sleep apnea is associated with fatigue in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

CANTO E , Reverter F, Morcillo-Suarez C, Matesanz F, et al
Chitinase 3-like 1 plasma levels are increased in patients with progressive forms of multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

STROBER LB , Christodoulou C, Benedict RH, Westervelt HJ, et al
Unemployment in multiple sclerosis: the contribution of personality and disease.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

JOHANSSON KM , Nygren-Bonnier M, Schalling E
Effects of glossopharyngeal breathing on speech and respiration in multiple sclerosis: a case report.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

RISPENS T , Vennegoor A, Wolbink GJ, Polman CH, et al
Natalizumab remains detectable in patients with multiple sclerosis long after treatment is stopped.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

ETEMADIFAR M , Abtahi SH, Akbari M, Maghzi AH, et al
Multiple sclerosis and amyotrophic lateral sclerosis: is there a link?
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

CHITNIS T , Tenembaum S, Banwell B, Krupp L, et al
Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SCHWARTZ I , Sajin A, Moreh E, Fisher I, et al
Robot-assisted gait training in multiple sclerosis patients: a randomized trial.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

HAWKINS S
Truly benign multiple sclerosis is rare: let's stop fooling ourselves - No.
Mult Scler. 2011.
PubMed Text format Related articles

AMATO MP , Portaccio E
Truly benign multiple sclerosis is rare: let's stop fooling ourselves -Yes.
Mult Scler. 2011.
PubMed Text format Related articles

HUTCHINSON M
Truly benign multiple sclerosis is rare: let's stop fooling ourselves - Commentary.
Mult Scler. 2011.
PubMed Text format Related articles

HONAN CA , Brown RF, Hine DW, Vowels L, et al
The Multiple Sclerosis Work Difficulties Questionnaire.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

November 2011

IRIZAR H , Munoz-Culla M, Zuriarran O, Goyenechea E, et al
HLA-DRB1*15:01 and multiple sclerosis: a female association?
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

MANCARDI G , Sormani M, Di Gioia M, Vuolo L, et al
Autologous haematopoietic stem cell transplantation with an intermediate intensity conditioning regimen in multiple sclerosis: the Italian multi-centre experience.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

HAWTON A , Green C, Telford C, Wright D, et al
The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

CHIARINI M , Serana F, Zanotti C, Capra R, et al
Modulation of the central memory and Tr1-like regulatory T cells in multiple sclerosis patients responsive to interferon-beta therapy.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

CLAERBOUT M , Gebara B, Ilsbroukx S, Verschueren S, et al
Effects of 3 weeks' whole body vibration training on muscle strength and functional mobility in hospitalized persons with multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SIMPSON S JR , Taylor B, Dwyer DE, Taylor J, et al
Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

FOX E , Wynn D, Cohan S, Rill D, et al
A randomized clinical trial of autologous T-cell therapy in multiple sclerosis: subset analysis and implications for trial design.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

KWIATKOWSKI A , Gallois J, Bilbault N, Calais G, et al
Herpes encephalitis during natalizumab treatment in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

FEINSTEIN A
Multiple sclerosis and depression.
Mult Scler. 2011;17:1276-81.
PubMed Text format Related articles Abstract available

October 2011

MCFADDEN E , Horton MC, Ford HL, Gilworth G, et al
Screening for the risk of job loss in multiple sclerosis: development of an MS-pecific Work Instability Scale (MS-WIS).
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SAASTAMOINEN KP , Auvinen MK, Tienari PJ
Month of birth is associated with multiple sclerosis but not with HLA-DR15 in Finland.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

VON GLEHN F , Farias AS, Penalva de Oliveira AC, Damasceno A, et al
Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

LEBEL RM , Eissa A, Seres P, Blevins G, et al
Quantitative high field imaging of sub-cortical gray matter in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

BAZELIER MT , Mueller-Schotte S, Leufkens HG, Uitdehaag BM, et al
Risk of cataract and glaucoma in patients with multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SILVA AM , Santos E, Moreira I, Bettencourt A, et al
Olfactory dysfunction in multiple sclerosis: association with secondary progression.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SELLEBJERG F , Hedegaard C, Krakauer M, Hesse D, et al
Glatiramer acetate antibodies, gene expression and disease activity in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

BAZELIER MT , de Vries F, Bentzen J, Vestergaard P, et al
Incidence of fractures in patients with multiple sclerosis: the Danish National Health Registers.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

COMABELLA M , Kakalacheva K, Rio J, Munz C, et al
EBV-specific immune responses in patients with multiple sclerosis responding to IFN{beta} therapy.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SEDANI S , Lim M, Hemingway C, Wassmer E, et al
Paediatric multiple sclerosis: examining utility of the McDonald 2010 criteria.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

MAGHZI AH , Etemadifar M, Heshmat-Ghahdarijani K, Nonahal S, et al
Cesarean delivery may increase the risk of multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

KIERKEGAARD M , Einarsson U, Gottberg K, von Koch L, et al
The relationship between walking, manual dexterity, cognition and activity/participation in persons with multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

FEYS P , Gijbels D, Romberg A, Santoyo C, et al
Effect of time of day on walking capacity and self-reported fatigue in persons with multiple sclerosis: a multi-center trial.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

FREDERIKSEN J , Kristensen K, Bahl J, Christiansen M, et al
Tau protein: a possible prognostic factor in optic neuritis and multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

HUTCHINSON M
The major cause of multiple sclerosis is environmental: genetics has a minor role - Commentary.
Mult Scler. 2011;17:1176.
PubMed Text format Related articles

SAWCER S
The major cause of multiple sclerosis is environmental: genetics has a minor role - No.
Mult Scler. 2011;17:1174-5.
PubMed Text format Related articles

TAYLOR BV
The major cause of multiple sclerosis is environmental: genetics has a minor role - Yes.
Mult Scler. 2011;17:1171-3.
PubMed Text format Related articles

HUTCHINSON M
Controversies in multiple sclerosis: a series of debates.
Mult Scler. 2011;17:1170.
PubMed Text format Related articles

SHIELDS SD , Waxman SG
Cerebellar dysfunction in multiple sclerosis: in the blink of an eye.
Mult Scler. 2011;17:1152-4.
PubMed Text format Related articles

Abstracts of the 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis. October 19-22, 2011. Amsterdam, The Netherlands.
Mult Scler. 2011;17.
PubMed Text format Related articles

CORREALE J , Farez MF
The impact of environmental infections (parasites) on MS activity.
Mult Scler. 2011;17:1162-9.
PubMed Text format Related articles Abstract available

BEDI GS , Brown AD, Delgado SR, Usmani N, et al
Impact of rituximab on relapse rate and disability in neuromyelitis optica.
Mult Scler. 2011;17:1225-30.
PubMed Text format Related articles Abstract available

September 2011

BLAHOVA DUSANKOVA J , Kalincik T, Dolezal T, Kobelt G, et al
Cost of multiple sclerosis in the Czech Republic: The COMS Study.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

WYNIA K , Wijlen AV, Middel B, Reijneveld S, et al
Change in disability profile and quality of life in multiple sclerosis patients: a five-year longitudinal study using the Multiple Sclerosis Impact Profile (MSIP).
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

DURANTE L , Zaaraoui W, Rico A, Crespy L, et al
Intrathecal synthesis of IgM measured after a first demyelinating event suggestive of multiple sclerosis is associated with subsequent MRI brain lesion accrual.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

VUCIC S , Burke T, Lenton K, Ramanathan S, et al
Cortical dysfunction underlies disability in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

ZISSMAN K , Lejbkowicz I, Miller A
Telemedicine for multiple sclerosis patients: assessment using Health Value Compass.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

LEAVITT VM , Wylie G, Genova HM, Chiaravalloti ND, et al
Altered effective connectivity during performance of an information processing speed task in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

ZAFAR AB , Ness J, Dowdy S, Avis K, et al
Examining sleep, fatigue, and daytime sleepiness in pediatric multiple sclerosis patients.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

VRETHEM M , Kvarnstrom M, Stenstam J, Cassel P, et al
Cytokine mapping in cerebrospinal fluid and blood in multiple sclerosis patients without oligoclonal bands.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

GIJBELS D , Dalgas U, Romberg A, de Groot V, et al
Which walking capacity tests to use in multiple sclerosis? A multicentre study providing the basis for a core set.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SHIRANI A , Zhao Y, Kingwell E, Rieckmann P, et al
Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975-2009).
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

D'HOOGHE M , Haentjens P, Nagels G, Garmyn M, et al
Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SAJIC M , Gregson N, Linington C, Hughes RA, et al
The role of CD8+ T cells in a model of multiple sclerosis induced with recombinant myelin oligodendrocyte glycoprotein.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

GOODIN DS , Hartung HP, O'Connor P, Filippi M, et al
Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

RIGOTTI D , Gass A, Achtnichts L, Inglese M, et al
Multiple Sclerosis Severity Scale and whole-brain N-acetylaspartate concentration for patients' assessment.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

LU E , Dahlgren L, Sadovnick A, Sayao A, et al
Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

HAMALAINEN P , Ikonen A, Romberg A, Helenius H, et al
The effects of heat stress on cognition in persons with multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

PAZ SOLDAN MM , Pittock SJ, Weigand SD, Yawn BP, et al
Statin therapy and multiple sclerosis disability in a population-based cohort.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SCHOONHEIM MM , Hulst HE, Landi D, Ciccarelli O, et al
Gender-related differences in functional connectivity in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SONDER J , Bosma L, van der Linden F, Knol D, et al
Proxy measurements in multiple sclerosis: agreement on different patient-reported outcome scales.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

FEINSTEIN A
Multiple sclerosis, cognitive dysfunction and the potential benefits of exercise.
Mult Scler. 2011;17:1032-3.
PubMed Text format Related articles

KIM W , Kim SH, Lee SH, Li XF, et al
Brain abnormalities as an initial manifestation of neuromyelitis optica spectrum disorder.
Mult Scler. 2011;17:1107-12.
PubMed Text format Related articles Abstract available

JARIUS S , Jacobi C, de Seze J, Zephir H, et al
Frequency and syndrome specificity of antibodies to aquaporin-4 in neurological patients with rheumatic disorders.
Mult Scler. 2011;17:1067-73.
PubMed Text format Related articles Abstract available

August 2011

KAPPOS L , Gold R, Miller DH, Macmanus DG, et al
Effect of BG-12 on contrast-enhancing lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

NOTCUTT W , Langford R, Davies P, Ratcliffe S, et al
A placebo-controlled, parallel-group, randomised withdrawal study of subjects with symptoms of spasticity due to multiple sclerosis who are receiving long-term Sativex(R) (nabiximols).
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

CALABRESE R , Zampieri M, Mechelli R, Annibali V, et al
Methylation-dependent PAD2 upregulation in multiple sclerosis peripheral blood.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

FERNANDEZ O , Fernandez V, Guerrero M, Leon A, et al
Multiple sclerosis prevalence in Malaga, Southern Spain estimated by the capture-recapture method.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

DALTON C , Bodini B, Samson R, Battaglini M, et al
Brain lesion location and clinical status status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

JOENSEN P
Reply to comment on: 'Multiple sclerosis: variation of incidence of onset over time in the Faroe Islands'
Mult Scler. 2011.
PubMed Text format Related articles

WALLIN MT , Kurtzke JF
Reply to: Multiple sclerosis: variation of incidence of onset over time in the Faroe Islands.
Mult Scler. 2011.
PubMed Text format Related articles

CALABRESE M , Federle L, Bernardi V, Rinaldi F, et al
The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SCHLAEGER R , D'Souza M, Schindler C, Grize L, et al
Prediction of long-term disability in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

CORREALE J , Peirano I, Romano L
Benign multiple sclerosis: a new definition of this entity is needed.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

GOMEZ-MORENO M , Diaz-Sanchez M, Ramos-Gonzalez A
Application of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Spanish cohort of patients with clinically isolated syndromes.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

COSSBURN M , Ingram G, Hirst C, Ben-Shlomo Y, et al
Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SAIDHA S , Syc SB, Durbin MK, Eckstein C, et al
Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

HARRISON DM , Gladstone DE, Hammond E, Cheng J, et al
Treatment of relapsing-remitting multiple sclerosis with high-dose cyclophosphamide induction followed by glatiramer acetate maintenance.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

HUOLMAN S , Hamalainen P, Vorobyev V, Ruutiainen J, et al
The effects of rivastigmine on processing speed and brain activation in patients with multiple sclerosis and subjective cognitive fatigue.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

MARRIE RA , Cutter G, Tyry T
Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

MULLER M , Frese A, Nassenstein I, Hoppen M, et al
Serum from interferon-{beta}-1b-treated patients with early multiple sclerosis stabilizes the blood-brain barrier in vitro.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

LE BOUC R , Zephir H, Majed B, Verier A, et al
No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

GORETTI B , Portaccio E, Ghezzi A, Lori S, et al
Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

NIELSEN AS , Miravalle A, Langer-Gould A, Cooper J, et al
Maximally tolerated versus minimally effective dose: the case of rituximab in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles

FORN C , Rocca M, Valsasina P, Bosca I, et al
Functional magnetic resonance imaging correlates of cognitive performance in patients with a clinically isolated syndrome suggestive of multiple sclerosis at presentation: an activation and connectivity study.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

FAREZ MF , Ysrraelit MC, Fiol M, Correale J, et al
H1N1 vaccination does not increase risk of relapse in multiple sclerosis: a self-controlled case-series study.
Mult Scler. 2011.
PubMed Text format Related articles

MOKKINK L , Knol D, Uitdehaag B
Factor structure of Guy's Neurological Disability Scale in a sample of Dutch patients with multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

PROSPERINI L , Gianni C, Leonardi L, De Giglio L, et al
Escalation to natalizumab or switching among immunomodulators in relapsing multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

ELENEIN RG , Sharer LR, Cook SD, Pachner AR, et al
A second case of Marburg's variant of multiple sclerosis with vasculitis and extensive demyelination.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

COX MB , Ban M, Bowden NA, Baker A, et al
Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

KISTER I , Munger KL, Herbert J, Ascherio A, et al
Increased risk of multiple sclerosis among women with migraine in the Nurses' Health Study II.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SHERIDAN JP , Zhang Y, Riester K, Tang MT, et al
Intermediate-affinity interleukin-2 receptor expression predicts CD56bright natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

KEMPEN JC , de Groot V, Knol DL, Polman CH, et al
Community walking can be assessed using a 10-metre timed walk test.
Mult Scler. 2011;17:980-90.
PubMed Text format Related articles Abstract available

HELLWIG K , Haghikia A, Gold R
Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment.
Mult Scler. 2011;17:958-63.
PubMed Text format Related articles Abstract available

July 2011

TUR C , Penny S, Khaleeli Z, Altmann D, et al
Grey matter damage and overall cognitive impairment in primary progressive multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

BAGNATO F , Ikonomidou VN, van Gelderen P, Auh S, et al
Lesions by tissue specific imaging characterize multiple sclerosis patients with more advanced disease.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

KIM E , Cameron M, Lovera J, Schaben L, et al
American ginseng does not improve fatigue in multiple sclerosis: a single center randomized double-blind placebo-controlled crossover pilot study.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

MISTRY N , Tallantyre EC, Dixon JE, Galazis N, et al
Focal multiple sclerosis lesions abound in 'normal appearing white matter'
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

CARVALHO ML , Motta R, Konrad G, Battaglia MA, et al
A randomized placebo-controlled cross-over study using a low frequency magnetic field in the treatment of fatigue in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SORMANI M , Stromillo ML, Battaglini M, Signori A, et al
Modelling the distribution of cortical lesions in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SANTON A , Cristobal E, Aparicio M, Royuela A, et al
High frequency of co-infection by Epstein-Barr virus types 1 and 2 in patients with multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

ACASTER S , Swinburn P, Wang C, Stemper B, et al
Can the functional assessment of multiple sclerosis adapt to changing needs? A psychometric validation in patients with clinically isolated syndrome and early relapsing-remitting multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

MECHELLI R , Anderson J, Vittori D, Coarelli G, et al
Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

GOBBI C , Digesu G, Khullar V, El Neil S, et al
Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

TALLNER A , Waschbisch A, Wenny I, Schwab S, et al
Multiple sclerosis relapses are not associated with exercise.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SBARDELLA E , Tomassini V, Stromillo M, Filippini N, et al
Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

MONTALBAN X , Comi G, O'Connor P, Gold S, et al
Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

FRANCHIGNONI F , Giordano A, Ferriero G
On dimensionality of the DASH.
Mult Scler. 2011;17:891-2.
PubMed Text format Related articles

TEUNISSEN CE , Koel-Simmelink MJ, Pham TV, Knol JC, et al
Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.
Mult Scler. 2011;17:838-50.
PubMed Text format Related articles Abstract available

RITZENTHALER T , Dailler F, Vukusic S, Confavreux C, et al
First attack of Devic's neuromyelitis optica following endovascular treatment and rupture of brain arteriovenous malformation.
Mult Scler. 2011;17:895-6.
PubMed Text format Related articles

KIRA J
Astrocytopathy in Balo's disease.
Mult Scler. 2011;17:771-9.
PubMed Text format Related articles Abstract available

RIISE T , Kirkeleit J, Aarseth JH, Farbu E, et al
Risk of MS is not associated with exposure to crude oil, but increases with low level of education.
Mult Scler. 2011;17:780-7.
PubMed Text format Related articles Abstract available

SHINODA K , Matsushita T, Furuta K, Isobe N, et al
Wall-eyed bilateral internuclear ophthalmoplegia (WEBINO) syndrome in a patient with neuromyelitis optica spectrum disorder and anti-aquaporin-4 antibody.
Mult Scler. 2011;17:885-7.
PubMed Text format Related articles Abstract available

June 2011

KNIPPENBERG S , Smolders J, Thewissen M, Peelen E, et al
Effect of vitamin D3supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

MUNGER K , Levin L, O'Reilly E, Falk K, et al
Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

MOTL RW , Sandroff BM, Benedict RH
Cognitive dysfunction and multiple sclerosis: developing a rationale for considering the efficacy of exercise training.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

ROSSI S , Mancino R, Bergami A, Mori F, et al
Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SAYAO AL , Bueno AM, Devonshire V, Tremlett And The Ubc Ms Clinic Neurologists H, et al
The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

PANTANO P , Bernardi S, Tinelli E, Pontecorvo S, et al
Impaired cortical deactivation during hand movement in the relapsing phase of multiple sclerosis: a cross-sectional and longitudinal fMRI study.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

DODD K , Taylor N, Shields N, Prasad D, et al
Progressive resistance training did not improve walking but can improve muscle performance, quality of life and fatigue in adults with multiple sclerosis: a randomized controlled trial.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

PAPEIX C , Depaz R, Tourbah A, Stankoff B, et al
Dramatic worsening following plasma exchange in severe post-natalizumab withdrawal multiple sclerosis relapse.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

FERNANDEZ O , Baumstarck-Barrau K, Simeoni MC, Auquier P, et al
Patient characteristics and determinants of quality of life in an international population with multiple sclerosis: Assessment using the MusiQoL and SF-36 questionnaires.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

LAUER K
Multiple sclerosis incidence in the Faroe Islands.
Mult Scler. 2011.
PubMed Text format Related articles

VEAUTHIER C , Paul F
Fatigue in multiple sclerosis: which patient should be referred to a sleep specialist?
Mult Scler. 2011.
PubMed Text format Related articles

COCCO E , Sardu C, Massa R, Mamusa E, et al
Epidemiology of multiple sclerosis in south-western Sardinia.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

GIJBELS D , Eijnde B, Feys P
Comparison of the 2- and 6-minute walk test in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

LA RUSSA A , Cittadella R, Andreoli V, Valentino P, et al
Leber's hereditary optic neuropathy associated with a multiple-sclerosis-like picture in a man.
Mult Scler. 2011;17:763-6.
PubMed Text format Related articles Abstract available

VILLAR LM , Espino M, Roldan E, Marin N, et al
Increased peripheral blood CD5+ B cells predict earlier conversion to MS in high-risk clinically isolated syndromes.
Mult Scler. 2011;17:690-4.
PubMed Text format Related articles Abstract available

COLLONGUES N , Marignier R, Zephir H, Blanc F, et al
High-risk syndrome for neuromyelitis optica: a descriptive and comparative study.
Mult Scler. 2011;17:720-4.
PubMed Text format Related articles Abstract available

ENZINGER C , Fuchs S, Pichler A, Wallner-Blazek M, et al
Predicting the severity of relapsing-remitting MS: the contribution of cross-sectional and short-term follow-up MRI data.
Mult Scler. 2011;17:695-701.
PubMed Text format Related articles Abstract available

May 2011

BENNETTO L , Burrow J, Sakai H, Cobby J, et al
The relationship between relapse, impairment and disability in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

CADAVID D , Kim S, Peng B, Skurnick J, et al
Clinical consequences of MRI activity in treated multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

VERCELLINO M , Grifoni S, Romagnolo A, Masera S, et al
Progranulin expression in brain tissue and cerebrospinal fluid levels in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

RAMPELLO L , Casolla B, Rampello L, Pignatelli M, et al
The conditioned eyeblink reflex: a potential tool for the detection of cerebellar dysfunction in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

LINCOLN NB , Yuill F, Holmes J, Drummond AE, et al
Evaluation of an adjustment group for people with multiple sclerosis and low mood: a randomized controlled trial.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

RIISE T , Kirkeleit J, Aarseth JH, Farbu E, et al
Response to Dr H Zhang's letter on 'Risk of multiple sclerosis is not associated with exposure to crude oil, but increases with a low level of education'
Mult Scler. 2011.
PubMed Text format Related articles

ZHANG H
Risk of multiple sclerosis is not associated with exposure to crude oil, but increases with a low level of education.
Mult Scler. 2011.
PubMed Text format Related articles

NICHOLAS R , Straube S, Schmidli H, Schneider S, et al
Trends in annualized relapse rates in relapsing-remitting multiple sclerosis and consequences for clinical trial design.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

GOVEROVER Y , Basso M, Wood H, Chiaravalloti N, et al
Examining the benefits of combining two learning strategies on recall of functional information in persons with multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

HENGSTMAN G , Kuesters B
Sudden cardiac death in multiple sclerosis caused by active demyelination of the medulla oblongata.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

RIETBERG MB , van Wegen EE, Uitdehaag BM, Kwakkel G, et al
The association between perceived fatigue and actual level of physical activity in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

ROOSENDAAL SD , Bendfeldt K, Vrenken H, Polman CH, et al
Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

FINLAYSON M , Preissner K, Cho C, Plow M, et al
Randomized trial of a teleconference-delivered fatigue management program for people with multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

MOLLER F , Poettgen J, Broemel F, Neuhaus A, et al
HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

WELLEK A , Korsukewitz C, Bach JP, Schock S, et al
Sibling disability risk at onset and during disease progression in familial multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

LINDQUIST S , Hassinger S, Lindquist JA, Sailer M, et al
The balance of pro-inflammatory and trophic factors in multiple sclerosis patients: effects of acute relapse and immunomodulatory treatment.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SEEWANN A , Vrenken H, Kooi EJ, van der Valk P, et al
Imaging the tip of the iceberg: visualization of cortical lesions in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SUMOWSKI JF , Chiaravalloti N, Erlanger D, Kaushik T, et al
L-amphetamine improves memory in MS patients with objective memory impairment.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

RISCO J , Maldonado H, Luna L, Osada J, et al
Latitudinal prevalence gradient of multiple sclerosis in Latin America.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

KIY G , Lehmann P, Hahn HK, Eling P, et al
Decreased hippocampal volume, indirectly measured, is associated with depressive symptoms and consolidation deficits in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

NELSON F , Datta S, Garcia N, Rozario NL, et al
Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles

SOMBEKKE M , van der Voort L, Kragt J, Nielsen J, et al
Relevance of IL7R genotype and mRNA expression in Dutch patients with multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles

KHAN O
Cerebrospinal venous insufficiency and multiple sclerosis: investigating the truth.
Mult Scler. 2011;17:511-2.
PubMed Text format Related articles

FRISULLO G , Iorio R, Plantone D, Marti A, et al
CD4+T-bet+, CD4+pSTAT3+ and CD8+T-bet+ T cells accumulate in peripheral blood during NZB treatment.
Mult Scler. 2011;17:556-66.
PubMed Text format Related articles Abstract available

April 2011

SORENSEN PS , Jensen PE, Haghikia A, Lundkvist M, et al
Occurrence of antibodies against natalizumab in relapsing multiple sclerosis patients treated with natalizumab.
Mult Scler. 2011.
PubMed Text format Related articles

LI K , Zhao B, Dai D, Yao S, et al
A functional p.82G>S polymorphism in the RAGE gene is associated with multiple sclerosis in the Chinese population.
Mult Scler. 2011.
PubMed Text format Related articles

ELIASDOTTIR OJ , Olafsson E, Kjartansson O
Incidence of multiple sclerosis in Iceland 2002-2007: a population-based study.
Mult Scler. 2011.
PubMed Text format Related articles

STENAGER EN , Jensen B, Stenager M, Stenager K, et al
Suicide attempts in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles

ANDERSON V , Wheeler-Kingshott C, Abdel-Aziz K, Miller D, et al
A comprehensive assessment of cerebellar damage in multiple sclerosis using diffusion tractography and volumetric analysis.
Mult Scler. 2011.
PubMed Text format Related articles

PATTI F , Amato M, Trojano M, Bastianello S, et al
Quality of life, depression and fatigue in mildly disabled patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon beta-1a: 3-year results from the COGIMUS (COGnitive Impairment in MUltiple Sclerosis) study.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

TAM R , Traboulsee A, Riddehough A, Sheikhzadeh F, et al
The impact of intensity variations in T1-hypointense lesions on clinical correlations in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

ANDREASEN A , Stenager E, Dalgas U
The effect of exercise therapy on fatigue in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

AMEZCUA L , Lund B, Weiner L, Islam T, et al
Multiple sclerosis in Hispanics: a study of clinical disease expression.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

KELLY S , Chaila E, Kinsella K, Duggan M, et al
Multiple Sclerosis, from referral to confirmed diagnosis: an audit of clinical practice.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

AHLGREN C , Oden A, Lycke J
High nationwide prevalence of multiple sclerosis in Sweden.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

ETEMADIFAR M , Maghzi AH
Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

Multiple sclerosis journal: reviewers in 2010.
Mult Scler. 2011;17:501-4.
PubMed Text format Related articles

SANDBERG-WOLLHEIM M , Kornmann G, Bischof D, Moraga MS, et al
The risk of malignancy is not increased in patients with multiple sclerosis treated with subcutaneous interferon beta-1a: analysis of data from clinical trial and post-marketing surveillance settings.
Mult Scler. 2011;17:431-40.
PubMed Text format Related articles Abstract available

HUTCHINSON M
Safety first, efficacy second in disease modifying therapies.
Mult Scler. 2011;17:380-1.
PubMed Text format Related articles

March 2011

MATZKE B , Metze C, Winkelmann A, Grossmann A, et al
Severe relapse of multiple sclerosis during plasma exchange treatment.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

PHILLIPS JT , Giovannoni G, Lublin FD, O'Connor PW, et al
Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

WALKER MA
Report of extracranial venous stenoses in relapsing-remitting multiple sclerosis patients.
Mult Scler. 2011.
PubMed Text format Related articles

CUNNEA P , Ni Mhaille A, McQuaid S, Farrell M, et al
Expression profiles of endoplasmic reticulum stress-related molecules in demyelinating lesions and multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

ZHANG H
B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica and multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles

HEDSTROM A , Baarnhielm M, Olsson T, Alfredsson L, et al
Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

YAMOUT B , Herlopian A, Issa Z, Habib R, et al
Authors' reply to 'Report of extracranial venous stenosis in relapsing-remitting multiple sclerosis patients'
Mult Scler. 2011.
PubMed Text format Related articles

RAGHEB S , Li Y, Simon K, Vanhaerents S, et al
Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

BAKER D , Gerritsen W, Rundle J, Amor S, et al
Critical appraisal of animal models of multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

REUTER F , Zaaraoui W, Crespy L, Faivre A, et al
Cognitive impairment at the onset of multiple sclerosis: relationship to lesion location.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

LUTTEROTTI A , Vedovello M, Reindl M, Ehling R, et al
Olfactory threshold is impaired in early, active multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

HVIID LE , Healy BC, Rintell DJ, Chitnis T, et al
Patient reported outcomes in benign multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

FLEMING J , Isaak A, Lee J, Luzzio C, et al
Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

VIRTA JR , Laatu S, Parkkola R, Oikonen V, et al
Cerebral acetylcholinesterase activity is not decreased in MS patients with cognitive impairment.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

GIOVANNONI G
Cannabinoids and B cells: emerging targets for treating progressive multiple sclerosis.
Mult Scler. 2011;17:259-61.
PubMed Text format Related articles

ROVARIS M , Rocca MA, Barkhof F, Calabrese M, et al
Relationship between brain MRI lesion load and short-term disease evolution in non-disabling MS: a large-scale, multicentre study.
Mult Scler. 2011;17:319-26.
PubMed Text format Related articles Abstract available

BORRIELLO G , Prosperini L, Marinelli F, Fubelli F, et al
Observations during an elective interruption of natalizumab treatment: a post-marketing study.
Mult Scler. 2011;17:372-5.
PubMed Text format Related articles Abstract available

STAUCH C , Reiber H, Rauchenzauner M, Strasak A, et al
Intrathecal IgM synthesis in pediatric MS is not a negative prognostic marker of disease progression: quantitative versus qualitative IgM analysis.
Mult Scler. 2011;17:327-34.
PubMed Text format Related articles Abstract available

February 2011

MATIELLO M
Corrigendum, 'Association of IL2RA polymorphisms with susceptibility to multiple sclerosis is not explained by missense mutations in IL2RA'
Mult Scler. 2011.
PubMed Text format Related articles

SMERBECK A , Parrish J, Serafin D, Yeh E, et al
Visual-cognitive processing deficits in pediatric multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

LE PAGE E , Leray E, Edan G
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective study.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

ALONSO A , Cook SD, Maghzi AH, Divani AA, et al
A case-control study of risk factors for multiple sclerosis in Iran.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

MILLER D , Weinstock-Guttman B, Bourdette D, You X, et al
Change in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: results from a trial of intramuscular interferon {beta}-1a.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

GARCIA-MARTIN E , Pueyo V, Ara J, Almarcegui C, et al
Effect of optic neuritis on progressive axonal damage in multiple sclerosis patients.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

FREEDMAN MS , Cohen JA
Meta-analysis of bone marrow transplantation treatment studies: mixing 'apples and oranges'.
Mult Scler. 2011;17:131-2.
PubMed Text format Related articles

CAMACHO-HALILI M , George R, Gottesman M, Davis-Lorton M, et al
An approach to natalizumab hypersensitivity: a case series of induction of tolerance.
Mult Scler. 2011;17:250-3.
PubMed Text format Related articles Abstract available

VAVRICKA BM , Baumberger P, Russmann S, Kullak-Ublick GA, et al
Diagnosis of melanoma under concomitant natalizumab therapy.
Mult Scler. 2011;17:255-6.
PubMed Text format Related articles

WARNKE C , Smolianov V, Dehmel T, Andree M, et al
CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus.
Mult Scler. 2011;17:151-6.
PubMed Text format Related articles Abstract available

LAULE C , Vavasour IM, Leung E, Li DK, et al
Pathological basis of diffusely abnormal white matter: insights from magnetic resonance imaging and histology.
Mult Scler. 2011;17:144-50.
PubMed Text format Related articles Abstract available

GOUT O , Bouchareine A, Moulignier A, Deschamps R, et al
Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating event.
Mult Scler. 2011;17:164-72.
PubMed Text format Related articles Abstract available

KHALIL M , Enzinger C, Langkammer C, Petrovic K, et al
Cognitive impairment in relation to MRI metrics in patients with clinically isolated syndrome.
Mult Scler. 2011;17:173-80.
PubMed Text format Related articles Abstract available

January 2011

ERWIN A , Gudesblatt M, Bethoux F, Bennett SE, et al
Intrathecal baclofen in multiple sclerosis: Too little, too late?
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

VEAUTHIER C , Radbruch H, Gaede G, Pfueller C, et al
Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

KISTER I , Chamot E, Bacon JH, Cutter G, et al
Trend for decreasing Multiple Sclerosis Severity Scores (MSSS) with increasing calendar year of enrollment into the New York State Multiple Sclerosis Consortium.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

ZHANG Y , Traboulsee A, Zhao Y, Metz LM, et al
Texture analysis differentiates persistent and transient T1 black holes at acute onset in multiple sclerosis: A preliminary study.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

COLLETT J , Dawes H, Meaney A, Sackley C, et al
Exercise for multiple sclerosis: a single-blind randomized trial comparing three exercise intensities.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

BONAVITA S , Gallo A, Sacco R, Della Corte M, et al
Distributed changes in default-mode resting-state connectivity in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

MATIELLO M , Weinshenker BG, Atkinson EJ, Schaefer-Klein J, et al
Association of IL2RA polymorphisms with susceptibility to multiple sclerosis is not explained by missense mutations in IL2RA.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

COOK S , Vermersch P, Comi G, Giovannoni G, et al
Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

HOLMEN C , Piehl F, Hillert J, Fogdell-Hahn A, et al
A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

MEYER-SCHWICKERATH R , Haug C, Hacker A, Fink F, et al
Intracranial venous pressure is normal in patients with multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

CALABRESE M , Bernardi V, Atzori M, Mattisi I, et al
Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

CECCARELLI A , Rocca MA, Perego E, Moiola L, et al
Deep grey matter T2 hypo-intensity in patients with paediatric multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

SANDBERG-WOLLHEIM M , Alteri E, Stam Moraga M, Kornmann G, et al
Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a Therapy.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

MULVEY MR , Doupe M, Prout M, Leong C, et al
Staphylococcus aureus harbouring Enterotoxin A as a possible risk factor for multiple sclerosis exacerbations.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

OIKONEN M , Laaksonen M, Aalto V, Ilonen J, et al
Temporal relationship between environmental Influenza A and Epstein-Barr viral infections and high multiple sclerosis relapse occurrence.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

OWEN DR , Piccini P, Matthews PM
Towards molecular imaging of multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

MOWRY EM , James JA, Krupp LB, Waubant E, et al
Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis.
Mult Scler. 2011.
PubMed Text format Related articles Abstract available

WIPFLER P , Oppermann K, Pilz G, Afazel S, et al
Adhesion molecules are promising candidates to establish surrogate markers for natalizumab treatment.
Mult Scler. 2011;17:16-23.
PubMed Text format Related articles Abstract available

KALLENBACH K , Sander B, Tsakiri A, Wanscher B, et al
Neither retinal nor brain atrophy can be shown in patients with isolated unilateral optic neuritis at the time of presentation.
Mult Scler. 2011;17:89-95.
PubMed Text format Related articles Abstract available

December 2010

HEDEGAARD CJ , Sellebjerg F, Krakauer M, Hesse D, et al
Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

YANG Y , Sun R, Yang H, Zheng F, et al
-308 G>A of TNF-{alpha} gene promoter decreases the risk of multiple sclerosis: a meta-analysis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

AL JUMAH M , Kojan S, Al Khaathami A, Al Abdulkaream I, et al
Familial multiple sclerosis: does consanguinity have a role?
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

OLIVER B , Fernandez O, Orpez T, Alvarenga MP, et al
Kinetics and incidence of anti-natalizumab antibodies in multiple sclerosis patients on treatment for 18 months.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

KINCSES Z , Ropele S, Jenkinson M, Khalil M, et al
Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SASTRE-GARRIGA J , Alonso J, Renom M, Arevalo M, et al
A functional magnetic resonance proof of concept pilot trial of cognitive rehabilitation in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

QIU W , James I, Carroll WM, Mastaglia FL, et al
HLA-DR allele polymorphism and multiple sclerosis in Chinese populations: a meta-analysis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SORMANI M , Bonzano L, Roccatagliata L, de Stefano N, et al
Magnetic resonance imaging as surrogate for clinical endpoints in multiple sclerosis: data on novel oral drugs.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

ALVAREZ-LAFUENTE R , Blanco-Kelly F, Garcia-Montojo M, Martinez A, et al
CD46 in a Spanish cohort of multiple sclerosis patients: genetics, mRNA expression and response to interferon-beta treatment.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

CORREALE J , Fiol M
Chitinase effects on immune cell response in neuromyelitis optica and multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SKOV A , Skov T, Frederiksen J
Oligoclonal bands predict multiple sclerosis after optic neuritis: a literature survey.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

VAN DER WALT A , Stankovich J, Bahlo M, Taylor B, et al
Heterogeneity at the HLA-DRB1 allelic variation locus does not influence multiple sclerosis disease severity, brain atrophy or cognition.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

CHAN S , Kingwell E, Oger J, Yoshida E, et al
High-dose frequency beta-interferons increase the risk of liver test abnormalities in multiple sclerosis: A longitudinal study.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

BROEKMANS T , Roelants M, Feys P, Alders G, et al
Effects of long-term resistance training and simultaneous electro-stimulation on muscle strength and functional mobility in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

PLUTA-FUERST A , Petrovic K, Berger T, Fryze W, et al
Patient-reported quality of life in multiple sclerosis differs between cultures and countries: a cross-sectional Austrian-German-Polish study.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

KUMPFEL T , Gerdes L, Flaig M, Hohlfeld R, et al
Drug-induced Sweet's syndrome after mitoxantrone therapy in a patient with multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SORMANI MP , Stubinski B, Cornelisse P, Rocak S, et al
Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

ROSSI S , Buttari F, Studer V, Motta C, et al
The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

GRACIEN R , Kordulla M, Ziemann U
Paraneoplastic cerebellar degeneration mimicking development of secondary progressive multiple sclerosis in a patient with relapsing-remitting multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

KHADEMI M , Kockum I, Andersson ML, Iacobaeus E, et al
Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

VOLLMER TL , Wynn DR, Alam MS, Valdes J, et al
A phase 2, 24-week, randomized, placebo-controlled, double-blind study examining the efficacy and safety of an anti-interleukin-12 and -23 monoclonal antibody in patients with relapsing-remitting or secondary progressive multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

MEUTH SG , Bittner S, Seiler C, Gobel K, et al
Natalizumab restores evoked potential abnormalities in patients with relapsing-remitting multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

NEUTEBOOM RF , Verbraak E, Wierenga-Wolf AF, Voerman JS, et al
The monocyte transcriptome during pregnancy in multiple sclerosis: prominent expression of the Fc-receptor CD64.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

TUTUNCU M , Demirci NO, Ozer F, Saip S, et al
A patient with established primary progressive multiple sclerosis transitions to 'secondary' relapsing-remitting disease course following a fulminant demyelinating episode.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

MILLS RJ , Young CA
The relationship between fatigue and other clinical features of multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

KAUFMAN MD , Lee R, Norton H
Course of relapsing-remitting multiple sclerosis before, during and after natalizumab.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

VAKNIN-DEMBINSKY A , Brill L, Orpaz N, Abramsky O, et al
Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population.
Mult Scler. 2010;16:1453-7.
PubMed Text format Related articles Abstract available

TAYLOR BV , Pearson JF, Clarke G, Mason DF, et al
MS prevalence in New Zealand, an ethnically and latitudinally diverse country.
Mult Scler. 2010;16:1422-31.
PubMed Text format Related articles Abstract available

UZAWA A , Mori M, Arai K, Sato Y, et al
Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6.
Mult Scler. 2010;16:1443-52.
PubMed Text format Related articles Abstract available

AMATO MP , Portaccio E, Goretti B, Zipoli V, et al
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study.
Mult Scler. 2010;16:1474-82.
PubMed Text format Related articles Abstract available

November 2010

FERNANDEZ O , Alvarenga MP, Guerrero M, Leon A, et al
The efficacy of natalizumab in patients with multiple sclerosis according to level of disability: results of an observational study.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SOLA P , Mandrioli J, Simone AM, Ferraro D, et al
Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

NICOLETTI A , Patti F, Lo Fermo S, Messina S, et al
Increasing frequency of multiple sclerosis in Catania, Sicily: a 30-year survey.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

RUET A , Deloire MS, Ouallet JC, Molinier S, et al
Predictive factors for multiple sclerosis in patients with clinically isolated spinal cord syndrome.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

YAMOUT B , Herlopian A, Issa Z, Habib RH, et al
Extracranial venous stenosis is an unlikely cause of multiple sclerosis.
Mult Scler. 2010;16:1341-8.
PubMed Text format Related articles Abstract available

HEESEN C
Treating multiple sclerosis with information.
Mult Scler. 2010;16:1302.
PubMed Text format Related articles

LLUFRIU S , Pujol T, Blanco Y, Hankiewicz K, et al
T2 hypointense rims and ring-enhancing lesions in MS.
Mult Scler. 2010;16:1317-25.
PubMed Text format Related articles Abstract available

October 2010

KRAGT J , Nielsen J, van der Linden F, Polman C, et al
Disease progression in multiple sclerosis: combining physicians' and patients' perspectives?
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

JOENSEN P
Multiple sclerosis: variation of incidence of onset over time in the Faroe Islands.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

STERNBERG Z , Hennies C, Sternberg D, Bistulfi GL, et al
Plasma pentosidine: a potential biomarker in the management of multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

RUDICK R , Kappos L, Kinkel R, Clanet M, et al
Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

PANDIT L , Ban M, Sawcer S, Singhal B, et al
Evaluation of the established non-MHC multiple sclerosis loci in an Indian population.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

CANO S , Barrett L, Zajicek J, Hobart J, et al
Beyond the reach of traditional analyses: using Rasch to evaluate the DASH in people with multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

MCCLURG D , Hagen S, Hawkins S, Lowe-Strong A, et al
Abdominal massage for the alleviation of constipation symptoms in people with multiple sclerosis: a randomized controlled feasibility study.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

KROKKI O , Bloigu R, Reunanen M, Remes A, et al
Increasing incidence of multiple sclerosis in women in Northern Finland.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

MOTL RW , Dlugonski D, Wojcicki TR, McAuley E, et al
Internet intervention for increasing physical activity in persons with multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

BORNSEN L , Khademi M, Olsson T, Sorensen PS, et al
Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

RESTON JT , Uhl S, Treadwell JR, Nash RA, et al
Autologous hematopoietic cell transplantation for multiple sclerosis: a systematic review.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

CHOI IY , Lee SP, Denney D, Lynch S, et al
Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SCHULTHEISS T , Reichmann H, Ziemssen T
Rapidly progressive course of very late onset multiple sclerosis presenting with Parkinsonism: case report.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SATO D , Fujihara K
Neuromyelitis optica without typical opticospinal phenotype.
Mult Scler. 2010;16:1154-5.
PubMed Text format Related articles

PARRATT JD , Prineas JW
Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes.
Mult Scler. 2010;16:1156-72.
PubMed Text format Related articles Abstract available

KIM JS , Park YH, Kim SM, Kim SH, et al
A case of chronic progressive myelopathy.
Mult Scler. 2010;16:1255-7.
PubMed Text format Related articles Abstract available

TANAKA A , Yoshida T, Yamada T, Isayama R, et al
A case of cerebral aquaporinopathy.
Mult Scler. 2010;16:1252-4.
PubMed Text format Related articles Abstract available

September 2010

BLASCHEK A , Lohse P, Huss K, Borggraefe I, et al
Concurrent TNFRSF1A R92Q and pyrin E230K mutations in a child with multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SIVARAMAKRISHNAN R , Kaul B, Jain SB, Mendonca S, et al
Multiple sclerosis in a patient with membranous glomerulopathy: is vitamin D deficiency the culprit in the presence of HLA DRB1*1501 allele?
Mult Scler. 2010.
PubMed Text format Related articles

DESCHAMPS R , Paturel L, Jeannin S, Chausson N, et al
Different HLA class II (DRB1 and DQB1) alleles determine either susceptibility or resistance to NMO and multiple sclerosis among the French Afro-Caribbean population.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

CATENOIX H , Marignier R, Ritleng C, Dufour M, et al
Multiple sclerosis and epileptic seizures.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SOLARI A , Martinelli V, Trojano M, Lugaresi A, et al
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

LIM BC , Hwang H, Kim KJ, Hwang YS, et al
Relapsing demyelinating CNS disease in a Korean pediatric population: Multiple sclerosis versus neuromyelitis optica.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

FERRANDI C , Richard F, Tavano P, Hauben E, et al
Characterization of immune cell subsets during the active phase of multiple sclerosis reveals disease and c-Jun N-terminal kinase pathway biomarkers.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

EDSTROM M , Mellergard J, Mjosberg J, Jenmalm M, et al
Transcriptional characteristics of CD4+ T cells in multiple sclerosis: Relative lack of suppressive populations in blood.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

COEBERGH J , Roosendaal S, Polman C, Geurts J, et al
Acute severe memory impairment as a presenting symptom of multiple sclerosis: a clinical case study with 3D double inversion recovery MR imaging.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

MILLEFIORINI E , Cortese A, Di Rezze S, Barletta G, et al
The prevalence of multiple sclerosis in central Italy.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

TOMASSINI V , Johansen-Berg H, Leonardi L, Paixao L, et al
Preservation of motor skill learning in patients with multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

COMI G , Abramsky O, Arbizu T, Boyko A, et al
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

KAVIA R , De Ridder D, Constantinescu C, Stott C, et al
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

BOJAR M , Zajac M, Meluzinova E, Houzvickova E, et al
Treatment with azathioprine and cyclic methylprednisolone has little or no effect on bioactivity in anti-interferon beta antibody-positive patients with multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles

HEESEN C , Kleiter I, Nguyen F, Schaffler N, et al
Risk perception in natalizumab-treated multiple sclerosis patients and their neurologists.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

MARJA-LIISA S , Matti H, Irina E, Eero P, et al
Causes of death among patients with multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SOLARI A , Mattarozzi K, Vignatelli L, Giordano A, et al
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

AKBAR N , Honarmand K, Kou N, Levine B, et al
Validity of an Internet version of the Multiple Sclerosis Neuropsychological Questionnaire.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

MIKITA J , Dubourdieu-Cassagno N, Deloire MS, Vekris A, et al
Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of Multiple Sclerosis. Amelioration of clinical status by M2 activated monocyte administration.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

INUSAH S , Sormani MP, Cofield SS, Aban IB, et al
Assessing changes in relapse rates in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

ESPOSITO F , Radaelli M, Martinelli V, Sormani MP, et al
Comparative study of mitoxantrone efficacy profile in patients with relapsing-remitting and secondary progressive multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

POONAWALLA A , Datta S, Juneja V, Nelson F, et al
Composite MRI scores improve correlation with EDSS in multiple sclerosis.
Mult Scler. 2010;16:1117-25.
PubMed Text format Related articles Abstract available

MARRIOTT JJ , O'Connor PW
Lessons learned from long-term multiple sclerosis treatment trials.
Mult Scler. 2010;16:1028-30.
PubMed Text format Related articles

BAKER D , Amor S
Quality control of experimental autoimmune encephalomyelitis.
Mult Scler. 2010;16:1025-7.
PubMed Text format Related articles

AHLGREN C , Lycke J, Oden A, Andersen O, et al
High risk of MS in Iranian immigrants in Gothenburg, Sweden.
Mult Scler. 2010;16:1079-82.
PubMed Text format Related articles Abstract available

ANDERSON VM , Fisniku LK, Khaleeli Z, Summers MM, et al
Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study.
Mult Scler. 2010;16:1083-90.
PubMed Text format Related articles Abstract available

FINK F , Rischkau E, Butt M, Klein J, et al
Efficacy of an executive function intervention programme in MS: a placebo-controlled and pseudo-randomized trial.
Mult Scler. 2010;16:1148-51.
PubMed Text format Related articles Abstract available

August 2010

CHATAWAY J , Nicholas R, Todd S, Miller DH, et al
A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

RISTORI G , Mechelli R, Anderson J, Mengoni F, et al
Antiviral immune response in patients with multiple sclerosis, healthy siblings and twins.
Mult Scler. 2010.
PubMed Text format Related articles

BARTOSIK-PSUJEK H , Tabarkiewicz J, Pocinska K, Stelmasiak Z, et al
Immunomodulatory effects of vitamin D on monocyte-derived dendritic cells in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

MORROW S , O'Connor P, Polman C, Goodman A, et al
Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

JAFARI N , Broer L, Hoppenbrouwers IA, van Duijn CM, et al
Infectious mononucleosis-linked HLA class I single nucleotide polymorphism is associated with multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

HEALY BC , Glanz BI, Stankiewicz J, Buckle G, et al
A method for evaluating treatment switching criteria in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

CODECA C , Mori F, Kusayanagi H, Monteleone F, et al
Differential patterns of interhemispheric functional disconnection in mild and advanced multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

FREEMAN J , Gear M, Pauli A, Cowan P, et al
The effect of core stability training on balance and mobility in ambulant individuals with multiple sclerosis: a multi-centre series of single case studies.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

BAGNATO F , Salman Z, Kane R, Auh S, et al
T1 cortical hypointensities and their association with cognitive disability in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SHAHBAZI M , Ebadi H, Fathi D, Roshandel D, et al
HLA-DRB1*1501 intensifies the impact of IL-6 gene promoter polymorphism on the susceptibility to multiple sclerosis in Iranian population.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

CHAN A , Decard B, Franke C Ms, Grummel V, et al
Serum antibodies to conformational and linear epitopes of myelin oligodendrocyte glycoprotein are not elevated in the preclinical phase of multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

PATTEN SB , Berzins S, Metz LM
Challenges in screening for depression in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

GHEZZI A , Banwell B, Boyko A, Amato MP, et al
The management of multiple sclerosis in children: a European view.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

VESTERINEN HM , Sena ES, Ffrench-Constant C, Williams A, et al
Improving the translational hit of experimental treatments in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SOTGIU S , Mameli G, Serra C, Zarbo I, et al
Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

DALGAS U , Stenager E, Jakobsen J, Petersen T, et al
Muscle fiber size increases following resistance training in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

FREUND P , Wheeler-Kingshott C, Jackson J, Miller D, et al
Recovery after spinal cord relapse in multiple sclerosis is predicted by radial diffusivity.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

KIM W , Park MS, Lee SH, Kim SH, et al
Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

LEBRUN C , Blanc F, Brassat D, Zephir H, et al
Cognitive function in radiologically isolated syndrome.
Mult Scler. 2010;16:919-25.
PubMed Text format Related articles Abstract available

MATIELLO M , Schaefer-Klein J, Brum DG, Atkinson EJ, et al
HLA-DRB1*1501 tagging rs3135388 polymorphism is not associated with neuromyelitis optica.
Mult Scler. 2010;16:981-4.
PubMed Text format Related articles Abstract available

July 2010

CHEN SY , Lo CP, Hsu WL, Kao HW, et al
Modifications to the McDonald MRI dissemination in space criteria for use in Asians with classic multiple sclerosis: the Taiwanese experience.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

MORENO B , Fernandez-Diez B, Di Penta A, Villoslada P, et al
Preclinical studies of methylthioadenosine for the treatment of multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

STRANGE RC , Ramachandran S, Zeegers MP, Emes RD, et al
The Multiple Sclerosis Severity Score: associations with MC1R single nucleotide polymorphisms and host response to ultraviolet radiation.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

BERMEL RA , Rae-Grant AD, Fox RJ
Diagnosing multiple sclerosis at a later age: more than just progressive myelopathy.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

CALABRESE M , Rinaldi F, Grossi P, Mattisi I, et al
Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

GIORGIO A , Portaccio E, Stromillo ML, Marino S, et al
Cortical functional reorganisation and its relationship with brain structural damage in patients with benign multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

YOSHIMURA S , Ochi H, Isobe N, Matsushita T, et al
Altered production of brain-derived neurotrophic factor by peripheral blood immune cells in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

REJDAK K , Leary S, Petzold A, Thompson A, et al
Urinary neopterin and nitric oxide metabolites as markers of interferon {beta}-1a activity in primary progressive multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

DERETZI G , Kountouras J, Koutlas E, Zavos C, et al
Familial prevalence of autoimmune disorders in multiple sclerosis in Northern Greece.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

LECHNER-SCOTT J , Kerr T, Spencer B, Agland S, et al
The Audio Recorded Cognitive Screen (ARCS) in patients with multiple sclerosis: a practical tool for multiple sclerosis clinics.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

WEINGES-EVERS N , Brandt AU, Bock M, Pfueller CF, et al
Correlation of self-assessed fatigue and alertness in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

NEUTEBOOM RF , Verbraak E, Wierenga-Wolf AF, van Meurs M, et al
Pregnancy-induced fluctuations in functional T-cell subsets in multiple sclerosis patients.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

ESNOUF J , Taylor P, Mann G, Barrett C, et al
Impact on activities of daily living using a functional electrical stimulation device to improve dropped foot in people with multiple sclerosis, measured by the Canadian Occupational Performance Measure.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

ENEVOLD C , Oturai AB, Sorensen PS, Ryder LP, et al
Polymorphisms of innate pattern recognition receptors, response to interferon-beta and development of neutralizing antibodies in multiple sclerosis patients.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

TAN H , Yu J, Tabby D, Devries A, et al
Clinical and economic impact of a specialty care management program among patients with multiple sclerosis: a cohort study.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

ALEXANDER J , Harris M, Wells S, Mills G, et al
Alterations in serum MMP-8, MMP-9, IL-12p40 and IL-23 in multiple sclerosis patients treated with interferon-{beta}1b.
Mult Scler. 2010;16:801-809.
PubMed Text format Related articles Abstract available

CORTES NINO MDEL P , Tampieri D, Melancon D
Endovascular venous procedures for multiple sclerosis?
Mult Scler. 2010;16:771-2.
PubMed Text format Related articles

ANTEL J , Thompson A, Carroll W
Chronic cerebrospinal venous insufficiency.
Mult Scler. 2010;16:770.
PubMed Text format Related articles

June 2010

CORET F , Bosca I, Landete L, Magraner M, et al
Early diffuse demyelinating lesion in the cervical spinal cord predicts a worse prognosis in relapsing-remitting multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

CHENG E , Crandall CJ, Bever CT Jr, Giesser B, et al
Quality indicators for multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

MORGAN C , Aban I, Katholi C, Cutter G, et al
Modeling lesion counts in multiple sclerosis when patients have been selected for baseline activity.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

HEARN AP , Silber E
Osteoporosis in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

NIELSEN J , Uitdehaag B, Korteweg T, Barkhof F, et al
Performance of the Swanton multiple sclerosis criteria for dissemination in space.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

JALKANEN A , Alanen A, Airas L
Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

MALLAM E , Kemp K, Wilkins A, Rice C, et al
Characterization of in vitro expanded bone marrow-derived mesenchymal stem cells from patients with multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

BOSCA I , Villar L, Coret F, Magraner M, et al
Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

PAPADOPOULOS D , Mitsikostas D
Nocebo effects in multiple sclerosis trials: a meta-analysis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

LUNDKVIST M , Greiner E, Hillert J, Fogdell-Hahn A, et al
Multiple sclerosis patients lacking oligoclonal bands in the cerebrospinal fluid are less likely to develop neutralizing antibodies against interferon beta.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SHARAFADDINZADEH N , Moghtaderi A, Kashipazha D, Majdinasab N, et al
The effect of low-dose naltrexone on quality of life of patients with multiple sclerosis: a randomized placebo-controlled trial.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

GHANDEHARI K , Riasi HR, Nourian A, Boroumand AR, et al
Prevalence of multiple sclerosis in north east of Iran.
Mult Scler. 2010.
PubMed Text format Related articles

SOSNOFF JJ , Goldman MD, Motl RW
Real-life walking impairment in multiple sclerosis: preliminary comparison of four methods for processing accelerometry data.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SYC SB , Warner CV, Hiremath GS, Farrell SK, et al
Reproducibility of high-resolution optical coherence tomography in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

HEALY BC , Ikle D, Macklin EA, Cutter G, et al
Optimal design and analysis of phase I/II clinical trials in multiple sclerosis with gadolinium-enhanced lesions as the endpoint.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

WADE DT , Collin C, Stott C, Duncombe P, et al
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis.
Mult Scler. 2010;16:707-14.
PubMed Text format Related articles Abstract available

LAULE C , Vavasour IM, Zhao Y, Traboulsee AL, et al
Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis.
Mult Scler. 2010;16:670-7.
PubMed Text format Related articles Abstract available

LOLLI F , Franciotta D
Oligoclonal bands in tears.
Mult Scler. 2010;16:760.
PubMed Text format Related articles

LERDAL A , Johansson S, Kottorp A, von Koch L, et al
Psychometric properties of the Fatigue Severity Scale: Rasch analyses of responses in a Norwegian and a Swedish MS cohort.
Mult Scler. 2010;16:733-41.
PubMed Text format Related articles Abstract available

ALBERTYN C , O'Dowd S, McHugh J, Murphy R, et al
Compliance with McDonald criteria and red flag recognition in a general neurology practice in Ireland.
Mult Scler. 2010;16:678-84.
PubMed Text format Related articles Abstract available

KLEITER I , Schroder M, Lurding R, Schuierer G, et al
Early changes on electroencephalography in natalizumab-associated progressive multifocal leucoencephalopathy.
Mult Scler. 2010;16:749-53.
PubMed Text format Related articles Abstract available

May 2010

BOSMA L , Kragt J, Brieva L, Khaleeli Z, et al
Progression on the Multiple Sclerosis Functional Composite in MS: what is the optimal cut-off for the three components?
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

TOGHA M , Ahmadi Karvigh S, Nabavi M, Beladi Moghadam N, et al
Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a doubleblind randomized controlled trial.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

LOVERA J , Frohman E, Brown T, Bandari D, et al
Memantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

D'HOOGHE M , Nagels G, Bissay V, De Keyser J, et al
Modifiable factors influencing relapses and disability in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

CASTELLAZZI M , Tamborino C, Cani A, Negri E, et al
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

PFLEGER C , Flachs E, Koch-Henriksen N
Social consequences of multiple sclerosis. Part 2. Divorce and separation: a historical prospective cohort study.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

DALMAY F , Bhalla D, Nicoletti A, Cabrera-Gomez J, et al
Multiple sclerosis and solar exposure before the age of 15 years: case-control study in Cuba, Martinique and Sicily.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

LANGER-GOULD A , Albers K, Van Den Eeden S, Nelson L, et al
Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

VOLTZ R
Palliative care for multiple sclerosis: a counter-intuitive approach?
Mult Scler. 2010;16:515-7.
PubMed Text format Related articles

WU JS , James I, Wei Qiu, Castley A, et al
Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
Mult Scler. 2010;16:526-32.
PubMed Text format Related articles Abstract available

PORTACCIO E , Goretti B, Zipoli V, Iudice A, et al
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery.
Mult Scler. 2010;16:611-7.
PubMed Text format Related articles Abstract available

April 2010

GILMORE C , Cottrell D, Scolding N, Wingerchuk D, et al
A window of opportunity for no treatment in early multiple sclerosis?
Mult Scler. 2010.
PubMed Text format Related articles

SOMBEKKE MH , Arteta D, van de Wiel MA, Crusius JB, et al
Analysis of multiple candidate genes in association with phenotypes of multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

KOCH M , Zhao Y, Yee I, Guimond C, et al
Disease onset in familial and sporadic primary progressive multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

HUGOS C , Copperman L, Fuller B, Yadav V, et al
Clinical trial of a formal group fatigue program in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

TYNDALL A
Mesenchymal stem cells for multiple sclerosis: can we find the answer?
Mult Scler. 2010;16:386.
PubMed Text format Related articles

TAYLOR BV , Lucas RM, Dear K, Kilpatrick TJ, et al
Latitudinal variation in incidence and type of first central nervous system demyelinating events.
Mult Scler. 2010;16:398-405.
PubMed Text format Related articles Abstract available

March 2010

GILLETT A , Thessen Hedreul M, Khademi M, Espinosa A, et al
Interleukin 18 Receptor 1 expression distinguishes patients with multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

KRASULOVA E , Trneny M, Kozak T, Vackova B, et al
High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre10-yearexperience.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

BOCK M , Brandt AU, Dorr J, Pfueller CF, et al
Time domain and spectral domain optical coherence tomography in multiple sclerosis: A comparative cross-sectional study.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

VAN DEN ELSKAMP I , Knol D, Vrenken H, Karas G, et al
Lesional magnetization transfer ratio:a feasible outcome for remyelinating treatment trials in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

LO FERMO S , Barone R, Patti F, Laisa P, et al
Outcome of psychiatric symptoms presenting at onset of multiple sclerosis: a retrospective study.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

BRENNAN R , Burrows J, Bell M, Bromham L, et al
Strains of Epstein-Barr virus infecting multiple sclerosis patients.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

EDMONDS P , Hart S, Gao W, Vivat B, et al
Palliative care for people severely affected by multiple sclerosis: evaluation of a novel palliative care service.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

MASTORODEMOS V , Nikolakaki H, Tzagournissakis M, Kotzamani D, et al
Benign multiple sclerosis in Crete*
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

TALLANTYRE EC , Bo L, Al-Rawashdeh O, Owens T, et al
Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

BENTZEN J , Flachs EM, Stenager E, Bronnum-Hansen H, et al
Prevalence of multiple sclerosis in Denmark 1950-2005.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

GORGORAPTIS N , Wheeler-Kingshott CA, Jenkins TM, Altmann DR, et al
Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

LARON M , Cheng H, Zhang B, Schiffman JS, et al
Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

GIJBELS D , Alders G, Van Hoof E, Charlier C, et al
Predicting habitual walking performance in multiple sclerosis: relevance of capacity and self-report measures.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

GONSETTE RE , Sindic C, D'hooghe MB, De Deyn PP, et al
Boosting endogenous neuroprotection in multiple sclerosis: the ASsociation of Inosine and Interferon {beta} in relapsing-remitting Multiple Sclerosis (ASIIMS) trial.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

DE STEFANO N , Curtin F, Stubinski B, Blevins G, et al
Rapid benefits of a new formulation of subcutaneous interferon beta-1a in relapsing-remitting multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

HAWKES CH , Giovannoni G
The McDonald Criteria for Multiple Sclerosis: time for clarification.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

DIAZ-SANCHEZ M , Gomez-Moreno SM, Morales-Otal MA, Ramos-Gonzalez A, et al
Accuracy of MRI criteria for dissemination in space for the diagnosis of multiple sclerosis in patients with clinically isolated syndromes.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

STANKOVIC A , Dincic E, Ristic S, Lovrecic L, et al
Interleukin 7 receptor alpha polymorphism rs6897932 and susceptibility to multiple sclerosis in the Western Balkans.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

POMEROY I , Jordan E, Frank J, Matthews P, et al
Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

LAZZARINO G , Amorini A, Eikelenboom M, Killestein J, et al
Cerebrospinal fluid ATP metabolites in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

DELOIRE M , Ruet A, Hamel D, Bonnet M, et al
Early cognitive impairment in multiple sclerosis predicts disability outcome several years later.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

KOUNTOURAS J , Gavalas E, Deretzi G, Boziki M, et al
Helicobacter pylori with or without its neutrophil-activating protein may be the common denominator associated with multiple sclerosis and neuromyelitis optica.
Mult Scler. 2010;16:376-7.
PubMed Text format Related articles

BERETICH BD , Beretich TM
Authors' reply to 'Latitude and multiple sclerosis prevalence: vitamin D reduces risk of Epstein--Barr virus infection'.
Mult Scler. 2010;16:374-5.
PubMed Text format Related articles

POORJAVAD M , Derakhshandeh F, Etemadifar M, Soleymani B, et al
Oropharyngeal dysphagia in multiple sclerosis.
Mult Scler. 2010;16:362-5.
PubMed Text format Related articles Abstract available

COMABELLA M , Montalban X, Horga A, Messmer B, et al
Antiviral immune response in patients with multiple sclerosis and healthy siblings.
Mult Scler. 2010;16:355-8.
PubMed Text format Related articles Abstract available

KHALEELI Z , Ciccarelli O, Mizskiel K, Altmann D, et al
Lesion enhancement diminishes with time in primary progressive multiple sclerosis.
Mult Scler. 2010;16:317-24.
PubMed Text format Related articles Abstract available

BLECHARZ KG , Haghikia A, Stasiolek M, Kruse N, et al
Glucocorticoid effects on endothelial barrier function in the murine brain endothelial cell line cEND incubated with sera from patients with multiple sclerosis.
Mult Scler. 2010;16:293-302.
PubMed Text format Related articles Abstract available

GIOVANNONI G
Cerebrospinal fluid neurofilament: the biomarker that will resuscitate the 'Spinal Tap'.
Mult Scler. 2010;16:285-6.
PubMed Text format Related articles

LOVAS G , Nielsen JA, Johnson KR, Hudson LD, et al
Alterations in neuronal gene expression profiles in response to experimental demyelination and axonal transection.
Mult Scler. 2010;16:303-16.
PubMed Text format Related articles Abstract available

DALGAS U , Stenager E, Jakobsen J, Petersen T, et al
Fatigue, mood and quality of life improve in MS patients after progressive resistance training.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

February 2010

VASCONCELOS CC , Thuler LC, Dos Santos GA, Alvarenga MP, et al
Differences in the progression of primary progressive multiple sclerosis in Brazilians of African descent versus white Brazilian patients.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

ZHAO Y , Petkau A, Traboulsee A, Riddehough A, et al
Does MRI lesion activity regress in secondary progressive multiple sclerosis?
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

BERMEL R , Weinstock-Guttman B, Bourdette D, Foulds P, et al
Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

FINK F , Eling P, Rischkau E, Beyer N, et al
The association between California Verbal Learning Test performance and fibre impairment in multiple sclerosis: evidence from diffusion tensor imaging.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

KIRA JI , Minohara M, Li W, Matsushita T, et al
Authors' reply to Helicobacter pylori with or without its neutrophil-activating protein may be the common denominator associated with multiple sclerosis and neuromyelitis optica.
Mult Scler. 2010.
PubMed Text format Related articles

LANZILLO R , Orefice G, Quarantelli M, Rinaldi C, et al
Atorvastatin Combined To Interferon to Verify the Efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

QIU W , Bundell C, Wu JS, Castley A, et al
Low level of systemic autoimmunity in Western Australian multiple sclerosis patients.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

PROSPERINI L , Leonardi L, De Carli P, Mannocchi ML, et al
Visuo-proprioceptive training reduces risk of falls in patients with multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

INGRAM G , Colley E, Ben-Shlomo Y, Cossburn M, et al
Validity of patient-derived disability and clinical data in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

YADAV V , Marracci GH, Munar MY, Cherala G, et al
Pharmacokinetic study of lipoic acid in multiple sclerosis: comparing mice and human pharmacokinetic parameters.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

OZTURK A , Smith S, Gordon-Lipkin E, Harrison D, et al
MRI of the corpus callosum in multiple sclerosis: association with disability.
Mult Scler. 2010;16:166-77.
PubMed Text format Related articles Abstract available

BALASHOV KE , Pal G, Rosenberg ML
Optic neuritis incidence is increased in spring months in patients with asymptomatic demyelinating lesions.
Mult Scler. 2010;16:252-4.
PubMed Text format Related articles Abstract available

TEUNISSEN CE , Tumani HT, Bennett JL, Berven FS, et al
Short commentary on 'a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking'.
Mult Scler. 2010;16:129-32.
PubMed Text format Related articles

January 2010

FORD C , Goodman AD, Johnson K, Kachuck N, et al
Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis : results from the 15-year analysis of the US prospective open-label study of glatiramer acetate.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SWANTON J , Fernando K, Dalton C, Miszkiel K, et al
Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SINCLAIR V , Shepard G
Symptomatic, steroid-induced, multifocal diaphyseal osteonecrosis in a patient with multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

PAPADOPOULOS K , Tozer DJ, Fisniku L, Altmann DR, et al
T1-relaxation time changes over five years in relapsing-remitting multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

WINSEN LM , Polman CH, Dijkstra CD, Tilders FJ, et al
Suppressive effect of glucocorticoids on TNF-{alpha} production is associated with their clinical effect in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

VOGT MH , Ten Kate J, Drent RJ, Polman CH, et al
Increased osteopontin plasma levels in multiple sclerosis patients correlate with bone-specific markers.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

MESAROS S , Rocca M, Sormani M, Valsasina P, et al
Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SOMER E , Golan D, Dishon S, Cuzin-Disegni L, et al
Patients with multiple sclerosis in a war zone: coping strategies associated with reduced risk for relapse.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

MAGHZI A , Ghazavi H, Ahsan M, Etemadifar M, et al
Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

FREEDMAN MS , Bar-Or A, Atkins HL, Karussis D, et al
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

WINSEN LM , Kragt JJ, Hoogervorst EL, Polman CH, et al
Outcome measurement in multiple sclerosis: detection of clinically relevant improvement.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

SALZER J , Svenningsson A, Sundstrom P
Neurofilament light as a prognostic marker in multiple sclerosis.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

REUB R , Schreiber V, Klein A, Infante-Duarte C, et al
No significant effect of orally administered chemokine receptor 1 antagonist on intercellular adhesion molecule-3 expression in relapsing-remitting multiple sclerosis patients.
Mult Scler. 2010.
PubMed Text format Related articles Abstract available

PELAYO R , Montalban X, Minoves T, Moncho D, et al
Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?
Mult Scler. 2010;16:55-61.
PubMed Text format Related articles Abstract available

GOTTESMAN MH , Friedman-Urevich S, Boylan E, Cheng D, et al
Neutralizing antibodies to 500 microg interferon beta-1b: 28-month results of the IDEAS extension trial.
Mult Scler. 2010;16:78-80.
PubMed Text format Related articles Abstract available

ADONI T , Lino AM, da Gama PD, Apostolos-Pereira SL, et al
Recurrent neuromyelitis optica in Brazilian patients: clinical, immunological, and neuroimaging characteristics.
Mult Scler. 2010;16:81-6.
PubMed Text format Related articles Abstract available

November 2009

JUNG K
Consideration of preanalytical impact of blood sampling on measurement of matrix metalloproteinases and their inhibitors as precondition to evaluate their relationship to clinical data.
Mult Scler. 2009;15:1372-3.
PubMed Text format Related articles

CUTTER G
Evidence of treatment benefit: is seeing believing or obfuscation by statistics?
Mult Scler. 2009;15:1251-2.
PubMed Text format Related articles

October 2009

GARCEA O , Villa A, Caceres F, Adoni T, et al
Early treatment of multiple sclerosis: a Latin American experts meeting.
Mult Scler. 2009;15 Suppl 3:S1-S12.
PubMed Text format Related articles Abstract available

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from Bayer Schering Pharma AG.

Amedeo is a Flying Publisher website.
Design: